Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEFLUNOMIDE Cause C-reactive protein abnormal? 3,279 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 3,279 reports of C-reactive protein abnormal have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 5.8% of all adverse event reports for LEFLUNOMIDE.

3,279
Reports of C-reactive protein abnormal with LEFLUNOMIDE
5.8%
of all LEFLUNOMIDE reports
1,172
Deaths
2,054
Hospitalizations

How Dangerous Is C-reactive protein abnormal From LEFLUNOMIDE?

Of the 3,279 reports, 1,172 (35.7%) resulted in death, 2,054 (62.6%) required hospitalization, and 1,363 (41.6%) were considered life-threatening.

Is C-reactive protein abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 3,279 reports have been filed with the FAERS database.

What Other Side Effects Does LEFLUNOMIDE Cause?

Drug ineffective (31,396) Rheumatoid arthritis (20,886) Pain (15,594) Drug intolerance (14,142) Joint swelling (13,026) Fatigue (11,959) Arthralgia (11,880) Rash (11,239) Contraindicated product administered (11,206) Abdominal discomfort (10,333)

What Other Drugs Cause C-reactive protein abnormal?

METHOTREXATE (3,734) ADALIMUMAB (3,629) ETANERCEPT (3,592) ABATACEPT (3,402) TOCILIZUMAB (3,259) HYDROXYCHLOROQUINE (3,245) SULFASALAZINE (2,823) INFLIXIMAB (2,676) RITUXIMAB (2,608) TOFACITINIB (2,062)

Which LEFLUNOMIDE Alternatives Have Lower C-reactive protein abnormal Risk?

LEFLUNOMIDE vs LEMBOREXANT LEFLUNOMIDE vs LENACAPAVIR LEFLUNOMIDE vs LENALIDOMIDE LEFLUNOMIDE vs LENIOLISIB LEFLUNOMIDE vs LENOGRASTIM

Related Pages

LEFLUNOMIDE Full Profile All C-reactive protein abnormal Reports All Drugs Causing C-reactive protein abnormal LEFLUNOMIDE Demographics